Osteoprotegerin and inflammation
- PMID: 12101070
Osteoprotegerin and inflammation
Abstract
RANK, RANKL, and OPG have well established regulatory effects on bone metabolism. RANK is expressed at very high levels on osteoclastic precursors and on mature osteoclasts, and is required for differentiation and activation of the osteoclast. The ligand, RANKL binds to its receptor RANK to induce bone resorption. RANKL is a transmembrane protein expressed in various cells type and particularly on osteoblast and activated T cells. RANKL can be cleaved and the soluble form is active. Osteoprotegerin decoy receptor (OPG), a member of the TNF receptor family expressed by osteoblasts, strongly inhibits bone resorption by binding with high affinity to its ligand RANKL, thereby preventing RANKL from engaging its receptor RANK. This system is regulated by the calciotropic hormones. Conversely, the effects of RANKL, RANK, and OPG on inflammatory processes, most notably on the bone resorption associated with inflammation, remain to be defined. The RANK system seems to play a major role in modulating the immune system. Activated T cells express RANKL messenger RNA, and knock-out mice for RANKL acquire severe immunological abnormalities and osteopetrosis. RANKL secretion by activated T cells can induce osteoclastogenesis. These mechanisms are enhanced by cytokines such as TNF-alpha, IL-1, and IL-17, which promote both inflammation and bone resorption. Conversely, this system is blocked by OPG, IL-4, and IL-10, which inhibit both inflammation and osteoclastogenesis. These data may explain part of the abnormal phenomena in diseases such as rheumatoid arthritis characterized by both inflammation and destruction. Activated T cells within the rheumatoid synovium express RANKL. Synovial cells are capable of differentiating to osteoclast-like cells under some conditions, including culturing with M-CSF and RANKL. This suggests that the bone erosion seen in rheumatoid arthritis may result from RANKL/RANK system activation by activated T cells. This opens up the possibility that OPG may have therapeutic effects mediated by blockade of the RANKL/RANK system.
Similar articles
-
Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption.Medscape Womens Health. 2000 Mar;5(2):5. Medscape Womens Health. 2000. PMID: 10792853 Review.
-
Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.J Cell Biochem. 2003 Mar 1;88(4):650-9. doi: 10.1002/jcb.10436. J Cell Biochem. 2003. PMID: 12577299
-
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.Arthritis Rheum. 2004 Jan;50(1):277-90. doi: 10.1002/art.11487. Arthritis Rheum. 2004. PMID: 14730626
-
A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. doi: 10.1006/bbrc.1999.0252. Biochem Biophys Res Commun. 1999. PMID: 10080918 Review.
-
Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.Ann Rheum Dis. 2004 Nov;63(11):1379-86. doi: 10.1136/ard.2003.018481. Ann Rheum Dis. 2004. PMID: 15479886 Free PMC article.
Cited by
-
Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis.Eur Arch Otorhinolaryngol. 2015 Aug;272(8):1907-12. doi: 10.1007/s00405-014-3008-4. Epub 2014 Mar 28. Eur Arch Otorhinolaryngol. 2015. PMID: 24676726 Free PMC article.
-
The IL-10 and IFN-gamma pathways are essential to the potent immunosuppressive activity of cultured CD8+ NKT-like cells.Genome Biol. 2008;9(7):R119. doi: 10.1186/gb-2008-9-7-r119. Epub 2008 Jul 29. Genome Biol. 2008. PMID: 18664279 Free PMC article.
-
Development of Biomarker Models to Predict Outcomes in Lupus Nephritis.Arthritis Rheumatol. 2016 Aug;68(8):1955-63. doi: 10.1002/art.39623. Arthritis Rheumatol. 2016. PMID: 26867033 Free PMC article.
-
Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.Curr Diab Rep. 2005 Dec;5(6):430-5. doi: 10.1007/s11892-005-0050-z. Curr Diab Rep. 2005. PMID: 16316593 Review.
-
Fibronectin has multifunctional roles in posterior capsular opacification (PCO).Matrix Biol. 2020 Aug;90:79-108. doi: 10.1016/j.matbio.2020.02.004. Epub 2020 Mar 12. Matrix Biol. 2020. PMID: 32173580 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials